Basset, M., Kimmich, C., Schreck, N., Krzykalla, J., Dittrich, T., Veelken, K., . . . Schönland, S. (2021). Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: Results from a large cohort of patients with long follow-up. British journal of haematology, 195(2), . https://doi.org/10.1111/bjh.17685
Chicago-Zitierstil (17. Ausg.)Basset, Marco, et al. "Lenalidomide and Dexamethasone in Relapsed/refractory Immunoglobulin Light Chain (AL) Amyloidosis: Results from a Large Cohort of Patients with Long Follow-up." British Journal of Haematology 195, no. 2 (2021). https://doi.org/10.1111/bjh.17685.
MLA-Zitierstil (9. Ausg.)Basset, Marco, et al. "Lenalidomide and Dexamethasone in Relapsed/refractory Immunoglobulin Light Chain (AL) Amyloidosis: Results from a Large Cohort of Patients with Long Follow-up." British Journal of Haematology, vol. 195, no. 2, 2021, https://doi.org/10.1111/bjh.17685.